CytoDyn is a clinical-stage biotechnology company focused on the development and commercialization of leronlimab, an investigational humanized IgG4 monoclonal antibody (mAb) that is designed to bind to C-C chemokine receptor type 5 (CCR5), a protein on the surface of certain immune system cells that... CytoDyn is a clinical-stage biotechnology company focused on the development and commercialization of leronlimab, an investigational humanized IgG4 monoclonal antibody (mAb) that is designed to bind to C-C chemokine receptor type 5 (CCR5), a protein on the surface of certain immune system cells that is believed to play a role in numerous disease processes. CytoDyn is studying leronlimab in multiple therapeutic areas, including infectious disease, cancer, and autoimmune conditions. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.00779 | 5.22818791946 | 0.149 | 0.17 | 0.1471 | 928955 | 0.16129499 | CS |
4 | 0.02079 | 15.2867647059 | 0.136 | 0.209 | 0.125 | 1838868 | 0.15237206 | CS |
12 | 0.01979 | 14.4452554745 | 0.137 | 0.209 | 0.111 | 2015616 | 0.13856307 | CS |
26 | -0.00521 | -3.21604938272 | 0.162 | 0.315 | 0.111 | 2196347 | 0.15686771 | CS |
52 | -0.03021 | -16.1550802139 | 0.187 | 0.418 | 0.111 | 2409754 | 0.17861049 | CS |
156 | -2.32321 | -93.6778225806 | 2.48 | 2.54 | 0.111 | 2195162 | 0.43201068 | CS |
260 | -0.23301 | -59.7768086198 | 0.3898 | 10.01 | 0.111 | 3030175 | 2.05764851 | CS |
Symbol | Price | Vol. |
---|---|---|
RONNRonn Motor Group Inc (PK) | $ 0.0007 (-12.50%) | 153.51M |
GRLFGreen Leaf Innovations Inc (PK) | $ 0.00015 (50.00%) | 136.59M |
HMBLHUMBL Inc (PK) | $ 0.00015 (-25.00%) | 92.93M |
AITXArtificial Intelligence Technology Solutions Inc (PK) | $ 0.0028 (-3.45%) | 87.39M |
SINCSincerity Applied Materials Holdings Corporation (PK) | $ 0.0012 (-14.29%) | 75.92M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.